Skip to content
lifestyle.onebyfourstudio.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Rznomics
Rznomics Granted Orphan Medicinal Product Designation for RZ-001 for the Treatment of Glioma by the European Commission
October 22, 2026
Rznomics Receives Positive Opinion for Orphan Medicinal Product Designation of RZ-001 for Glioma
September 30, 2026
Rznomics Reports Major Advances in High-Efficiency Circular RNA Production in Nucleic Acids Research
September 7, 2026
Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
August 23, 2026
Rznomics Presents Clinical Interim Data for RZ-001 in Recurrent Glioblastoma at ASNO 2026
June 15, 2026